|
Volumn 142, Issue 12, 2001, Pages 5390-5393
|
Evidence for estrogenic contamination of the MAPK inhibitor PD98059
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (2 AMINO 3 METHOXYPHENYL)CHROMONE;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
ARTICLE;
BINDING AFFINITY;
BREAST CANCER;
CANCER CELL CULTURE;
CONCENTRATION RESPONSE;
DOSE RESPONSE;
DRUG EFFECT;
DRUG RECEPTOR BINDING;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ESTROGEN ACTIVITY;
HORMONE SENSITIVITY;
HUMAN;
HUMAN CELL;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
REPORTER GENE;
BINDING, COMPETITIVE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG CONTAMINATION;
ENZYME INHIBITORS;
ESTRADIOL;
ESTROGEN RECEPTOR ALPHA;
ESTROGENS;
FLAVONOIDS;
MITOGEN-ACTIVATED PROTEIN KINASES;
RECEPTORS, ESTROGEN;
TUMOR CELLS, CULTURED;
|
EID: 0035210802
PISSN: 00137227
EISSN: None
Source Type: Journal
DOI: 10.1210/en.142.12.5390 Document Type: Article |
Times cited : (12)
|
References (13)
|